Influence of circulating c-erbB-2 serum protein on response to adjuvant chemotherapy in node-positive breast cancer patients

By Fehm T.  

Breast Cancer Research and Treatment, Vol. 43, Iss. 1, 1997-03 ,pp. : 87-95

Springer Publishing Company

Access to resources Recommend Favorite

Ten-year follow-up of a randomized controlled trial of adjuvant clodronate treatment in node-positive breast cancer patients

By Saarto Tiina   Vehmanen Leena   Virkkunen Pekka   Blomqvist Carl  

Acta Oncologica, Vol. 43, Iss. 7, 2004-10 ,pp. : 650-656

Informa Healthcare

Access to resources Recommend Favorite

Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer

By Ananda Sumitra   Steer Christopher  

The Women's Oncology Review, Vol. 5, Iss. 2, 2005-06 ,pp. : 109-111

Informa Healthcare

Access to resources Recommend Favorite

Prognostic effect of amenorrhoea and elevated serum gonadotropin levels induced by adjuvant chemotherapy in premenopausal node-positive breast cancer patients - effect of adjuvant chemotherapy

By Poikonen P.   Saarto T.   Elomaa I.   Joensuu H.   Blomqvist C.  

European Journal of Cancer, Vol. 36, Iss. 1, 2000-01 ,pp. : 43-48

Elsevier

Access to resources Recommend Favorite

Matrix Metalloproteinase-2 (MMP-2) is Associated with the Risk for a Relapse in Postmenopausal Patients with Node-Positive Breast Carcinoma Treated with Antiestrogen Adjuvant Therapy

By Talvensaari-Mattila A.  

Breast Cancer Research and Treatment, Vol. 65, Iss. 1, 2001-01 ,pp. : 55-61

Springer Publishing Company

Access to resources Recommend Favorite